| Code | 14585 | ||||||||||
| MA number | 44/0138/00-S | ||||||||||
| Product Form: | tbl 25x40 mg (liek.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 60 | ||||||||||
| Container: | brown glass bottle | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 04.05.2000 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_Lanvis_09.2023.pdf
|
| PIL: |
PIL_Lanvis_09.2023.pdf
|
| Safety feature | Yes |
| Data update: | 29.05.2018 |
